Feedback / Questions
Opdivo (nivolumab) - Ono Pharma, BMS
TT11 - Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute
https://www.globenewswire.com/news-release/2022/08/17/2499770/0/en/Tessa-Therapeutics-Doses-First-Patient-in-Phase-1b-Clinical-Trial-Investigating-TT11-in-Combination-with-Nivolumab-for-the-Treatment-of-Relapsed-Refractory-Classical-Hodgkin-Lympho.html
Aug 17, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next